Changed epidemiology of ICU acquired bloodstream infections over 12 years in an Italian teaching hospital

Minerva Anestesiologica

Volumn 81, Issue 9, 2015, Pages 980-988

  Orsi, G B ^a   Giuliano, S ^a   Franchi, C ^b   Ciorba, V ^c   Protano, C ^a   Giordano, A ^a   Rocco, M ^b   Venditti, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Epidemiology; Etiology; Infection, blood; Intensive care units

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; COLISTIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOODSTREAM INFECTION; COMPARATIVE STUDY; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTENSIVE CARE UNIT ACQUIRED LABORATORY CONFIRMED BLOODSTREAM INFECTION; ITALIAN (CITIZEN); KLEBSIELLA; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; STAPHYLOCOCCUS; TEACHING HOSPITAL; AGED; BACTEREMIA; CROSS INFECTION; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL MORTALITY; ITALY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84942134063     PISSN: 03759393     EISSN: 18271596     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Sligl W, Taylor G, Brindley PG. Five years of nosocomial gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006;10:320-5.
2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H et al. Sepsis in european intensive care units: result of the SOAP study. Crit Care Med 2006;34: 344-53.
3. Wisplinghof H, Bischof T, Tallent SM, Seifert H, Wenzel R P, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
4. Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. Am J Infect Control 2012;40:227-32.
5. Kang CI, Kin SH, Park WB, Lee KD, Kim HB, Kim EC et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005;49:760-6.
6. Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinberger M. Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance and patients age. Eur J Microbiol Infect Dis 2008;27:1045-51.
7. Orsi GB, García-Fernández A, Giordano A, Venditti C, Bencardino A, Gianfreda R et al. Risk factors and clinical signifcance of endemic ertapenem resistant Klebsiella pneumoniae isolates in hospitalized patients. J Hosp Infect 2011;78:54-8.
8. Orsi GB, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M et al. Patient risk factors for outer membrane permeability and KPC producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. Infection 2013;41:61-7.
9. Orsi GB, Franchi C, Marrone R, Giordano A, Rocco M, Venditti M. Laboratory confrmed bloodstream infection etiology in an intensive care unit: eight years study. Ann Ig 2012;24:269-78.
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC defnitions for nosocomial infections. In: Olmsted R.N., editors. APIC Infection Control and Applied Epidemiology: Principles and Practice. St Louis: Mosby; 1996. p. A-1-A-20.
11. Maki DG, Kluger DM, Crnich CJ. Te risk of bloodstream infection in adults with diferent intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-71.
12. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
13. Polderman KH, Girbes AR. Central venous catheter use. Part 2: infectious complications. Intensive Care Med 2002;28:18-28.
14. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
15. Wilson ML. General principles of specimen collection and transport. Clin Infect Dis 1996;22:776-7.
16. Cohen Stuart J, Leverstein-Van Hall MA, Dutch working Party on the detection of highly resistant microorganisms. Guideline for phenotypic screening and confrmation of carbapenemases in Enterobacteriaceae. Int J Antimicob Agents 2010;36:205-10.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document. Wayne, PA
18. EUCAST breakpoint tables for interpretation of MIC's and zone diameters. [Internet]. Available from: http://www.eu-cast.org/clinical-breakpoints/ [cited on 2015, July 21].
19. Magiorakos A P, Srinivasan A, Carey RB, Carmeli Y, Fala-gas ME, Giske CG et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant becteria: an international expert proposal for interim standard defnitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.
20. Almirante B, Rodrìguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005;43:1829-35.
21. Velasco E, Portugal RD, Salluh JIF. A simple score to predict early death in adult cancer patients with bloodstream infections. J Infect 2009;59:332-6.
22. Orsi GB, Raponi M, Franchi C, Rocco M, Mancini C, Ven-ditti M. Surveillance and infection control in an intensive care unit. Infect Control Hosp Epidemiol 2005;26:321-5.
23. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line -associated bloodstream infections in US intensive care units, 1997-2007. JAMA 2009;301:727-36.
24. Marra AR, Camargo L F, Pignatari AC, Sukiennik T, Behar PR, Medeiros EA et al. Nosocomial bloodstream infections in brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 2011;49:1866-71.
25. Liu CY, Liao CH, Chen YC, Chang SC. Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006. J Micro-biol Immunol Infect 2010;43:416-29.
26. Gudiol C, Bodro M, Simonetti A, Tubau F, Gonzalez-Barca E, Cisnal M et al. Changing etiology, clinical features, antimicrobial resistance and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013;19:474-9.
27. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS et al. Veterans afairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419-30.
28. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococ-cus aureus, United States, 1999-2005. Emerg Infect Dis 2007;13:1840-6.
29. Klevens RM, Morrison MA, Nadle J, Petit S, Gersham K, Ray S et al. Invasive methicillin-resistant staphylococcus au-reus infections in the United States. JAMA 2007;298:1763-71.
30. Orsi GB, Falcone M, Venditti C. Surveillance and management of multi-drug resistant microrganisms. Expert Rev Anti Infect Ter 2011;9:653-79.
31. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972-6.
32. Gasink LB, Adelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009;30:1180-5.
33. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee D P. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-106.
34. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resist-ant Klebsiella pneumoniae acquisition among hospitalized adults and efect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-33.